logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

John J Bruno

This inventor holds 7 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1984-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John J Bruno. Retrieved from https://idiyas.com/inventor/john-j-bruno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 135(Granted Patents)


Company Filing History:

goldMedal7 out of 932 
 
Syntex (u.s.a.) Inc.
 patents

Years Active: 1984-1990

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4921862 - Carbostyril derivatives as combined thromboxane synthetase and (1990-05-01),
2. 4792561 - Carbostyril derivatives as combined thromboxane synthetase and (1988-12-20),
3. 4766127 - 2-(3-pyridylmethyl)naphthalene-6-carboxylic acid as a thromboxane (1988-08-23),
4. 4663320 - (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, (1987-05-05),
5. 4593029 - Novel .omega.-(N-imidazolyl)alkyl ethers of (1986-06-03),
6. 4551459 - Method of treating heart failure using (1985-11-05),
7. 4490371 - N,N-Di (1984-12-25),

Title: The Innovations of John J Bruno

Introduction

John J Bruno is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 7 patents to his name, Bruno's work has had a substantial impact on medical science.

Latest Patents

One of his latest patents involves carbostyril derivatives that serve as combined thromboxane synthetase inhibitors. This invention focuses on a method to inhibit both thromboxane synthetase and cyclic-AMP phosphodiesterase in mammals suffering from diseases characterized by elevated thromboxane levels or an imbalance of prostacyclin/thromboxane levels. The compound formula used in this invention is designed to provide a pharmaceutically acceptable acid addition salt or ester, showcasing Bruno's innovative approach to complex medical challenges.

Career Highlights

Bruno has been associated with Syntex (U.S.A.) Inc., where he has played a pivotal role in advancing pharmaceutical research and development. His expertise in the field has led to breakthroughs that enhance therapeutic options for various medical conditions.

Collaborations

Throughout his career, John J Bruno has collaborated with esteemed colleagues, including Michael C Venuti and Gregory R Martinez. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John J Bruno's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving health outcomes. His work continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…